Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
“Only way I can see any possibility...
A Direct Listing on NASDAQ Global as a newly formed UNVC Conglomerate, the 'old' UNVC gets rolled in as part of the new company along with any other entities. Share structure transferred from the 'old' UNVC, or shares issued via the existing NOBO list (Non-Objecting Beneficial Owners). Doc has apparently been acting as his own Transfer Agent, which would make this process relatively straightforward.
IF the various company values often touted are correct (Health Resources, PPSI, Wellness RX etc), they would likely qualify in terms of shareholder equity, public float, number of shareholders, and overall assets.
They would not qualify for a regular exchange uplist, nor a traditional IPO due to the minimum PPS requirement - but Direct Listing effectively nullifies any minimum PPS. Initial estimated share price would be set by an accredited independent third party, and trading minimums would have to be met within a negotiated period.
The Direct Listing does not require the company to raise capital as in a traditional IPO, in fact, there are no 'new' shares on offer - and as such there would be no lockout period for existing shareholders - the exchange would actually rely on those shares to begin trading, and the initial price discovery would be market-driven.
It is possible to apply for a Direct Listing 'confidentially', so if it were in process we would have no way of knowing it until either (A) Cold open on NASDAQ, or (B) Registration Statement is filed 15 days prior to some kind of 'investor day', as required by NASDAQ regulations when promoting the stock to the public and institutional investors prior to open trading.
If the good Doc was pursuing a Direct Listing on the above basis, there would also be no need to get the existing UNVC current and reporting - and may also explain why 'Conglomerate Inc' has not been officially added to the existing ticker.
This is the only plausible route to an upper exchange I can currently see - if it were to actually happen I would also expect a barrage of PR's coinciding with launch - CARF, VA, Euromed, Telehealth, partners and alliances, new and upcoming products, extended services etc etc. This would create a liquid market for the shares on the first day of trading, and generate demand from institutional investors and hedge funds.
If it happens, we can all thank Spotify.” -posted by 4C previously
Sounds good. Thank you.
If they sell their stores then how are they going to make money selling cannabis over the long term?
I agree. Something is going on and someone is buying shares up.
$$$ ECOS $$$
Sounds like the same thing that TRTC did to their own shareholders.
The UNVC float has dried up just like Dalton had said it would and that is why you don’t see a lot of volume. Longs are holding strong for dollars and fireworks.
“Regulations,national and international,Negotiations, Frustration
Believers and naysayers,
Silence and Quiet
Long term shareholders always
saves the day. Float dry up and flippers. Univec Conglomerate Inc. The real deal. I promised a rainbow, may also have to add fireworks” - UNVC CEO David Dalton
Regulations,national and international,Negotiations, Frustration
— Dr. David Dalton (@DrDavidDalton1) December 8, 2019
Believers and naysayers,
Silence and Quiet
Long term shareholders always
saves the day. Float dry up and flippers. Univec Conglomerate Inc. The real deal. I promised a rainbow, may also have to add fireworks
“All is good going to great”- UNVC CEO David Dalton from moments ago.
All is good going to great
— Dr. David Dalton (@DrDavidDalton1) November 6, 2020
“Pennies to dollars
Nasdaq”-UNVC CEO Dr. David Dalton
Pennies to dollars
— Dr. David Dalton (@DrDavidDalton1) October 19, 2020
Nasdaq
Yes I think you are right on this being a breakthrough.
$$$ UNVC $$$
“Pennies to dollars
Nasdaq” - UNVC CEO Dr. David Dalton
Pennies to dollars
— Dr. David Dalton (@DrDavidDalton1) October 19, 2020
Nasdaq
Ha ha ha. UNVC = NASDAQ
$$$ UNVC $$$
What website did that post come from?
$$$ UNVC $$$
Do you have a link for that post?
$$$ UNVC $$$
Where did your copy and paste quote come from? Can you provide a link?
$$$ UNVC $$$
UNVC = NASDAQ
Since you are requesting links, why don’t you provide a link to the quote that you copied and pasted?
$$$ UNVC $$$
I am not an attorney.
This was posted on Twitter minutes ago:
“Pennies to dollars Nasdaq”- Dr. David Dalton UNVC (Univec Conglomerate CEO)
Pennies to dollars
— Dr. David Dalton (@DrDavidDalton1) October 19, 2020
Nasdaq
This was posted on Twitter minutes ago:
“Pennies to dollars Nasdaq”- Dr. David Dalton UNVC (Univec Conglomerate CEO)
Pennies to dollars
— Dr. David Dalton (@DrDavidDalton1) October 19, 2020
Nasdaq
“Pennies to dollars
Nasdaq”- Dr. David Dalton UNVC (Univec Conglomerate CEO)
Pennies to dollars
— Dr. David Dalton (@DrDavidDalton1) October 19, 2020
Nasdaq
A little more volume today. Someone bought and sold at the same time.
$$$ ECOS $$$
How do you know UNVC wont be? You sound very presumptive and somewhat hopeful there wont be any positive info.
This is the Novitas website where you can input DCN #: 301750406 and it should show Wellness RX Corporation (UNVC Subsidiary) medicare approval: https://providerstatustool.novitas-solutions.com $$$ UNVC $$$ Wellness Rx (UNVC subsidiary)
UNVC CEO Dr. David Dalton is rolling up multiple companies into Univec Conglomerate.
You the man hedgebunny. UNVC is going to make many millionaires. SmittyTNT introduced UNVC to me three years ago when I bought in the trips. I still have all of my UNVC shares.
4c posted this and may answer your question:
“A Direct Listing on NASDAQ Global as a newly formed UNVC Conglomerate, the 'old' UNVC gets rolled in as part of the new company along with any other entities. Share structure transferred from the 'old' UNVC, or shares issued via the existing NOBO list (Non-Objecting Beneficial Owners). Doc has apparently been acting as his own Transfer Agent, which would make this process relatively straightforward.
IF the various company values often touted are correct (Health Resources, PPSI, Wellness RX etc), they would likely qualify in terms of shareholder equity, public float, number of shareholders, and overall assets.
They would not qualify for a regular exchange uplist, nor a traditional IPO due to the minimum PPS requirement - but Direct Listing effectively nullifies any minimum PPS. Initial estimated share price would be set by an accredited independent third party, and trading minimums would have to be met within a negotiated period.
The Direct Listing does not require the company to raise capital as in a traditional IPO, in fact, there are no 'new' shares on offer - and as such there would be no lockout period for existing shareholders - the exchange would actually rely on those shares to begin trading, and the initial price discovery would be market-driven.
It is possible to apply for a Direct Listing 'confidentially', so if it were in process we would have no way of knowing it until either (A) Cold open on NASDAQ, or (B) Registration Statement is filed 15 days prior to some kind of 'investor day', as required by NASDAQ regulations when promoting the stock to the public and institutional investors prior to open trading.
If the good Doc was pursuing a Direct Listing on the above basis, there would also be no need to get the existing UNVC current and reporting - and may also explain why 'Conglomerate Inc' has not been officially added to the existing ticker.
This is the only plausible route to an upper exchange I can currently see - if it were to actually happen I would also expect a barrage of PR's coinciding with launch - CARF, VA, Euromed, Telehealth, partners and alliances, new and upcoming products, extended services etc etc. This would create a liquid market for the shares on the first day of trading, and generate demand from institutional investors and hedge funds.
If it happens, we can all thank Spotify.”
Why would you even say that? Unreal.
When I look at the breakout board on ihub it shows Univec Conglomerate and UNVC as one. How did that occur? Are they one in the same according to ihub?
$$$ UNVC $$$
Univec Conglomerate
When I look at the breakout board on ihub it shows Univec Conglomerate and UNVC as one. How did that occur?
$$$ UNVC $$$
Univec Conglomerate
UNVC shareholders have earned their positions. When UNVC hits the NASDAQ, there will be some that didn’t have the foresight to be a loyal long and instead they will be perched up on a barstool at Applebee’s eating fried onion rings and guzzling a mug of beer in sorrow.
$$$ UNVC $$$
Thank you for that post. It was the most intelligent and logical description on how Univec Conglomerate may proceed with the NASDAQ listing.
Thank you.
$$$ UNVC $$$
Yes I do think it is illegal as described by this article written by David Dayen.
UNVC will prevail.
https://theintercept.com/2016/09/23/big-players-little-stocks-and-naked-shorts/
“CHRIS DIIORIO HAD lost a million dollars when the penny stock he was betting on shed 98 percent of its value in a matter of weeks. But when he looked deeper, he found this wasn’t a typical penny stock pump-and-dump scheme. He was determined to get to the bottom of it.
For one thing, there were two huge companies involved.
UBS, one of the world’s largest private banks, seemed to have no business trading in penny stocks. “This was a $50 billion-plus bank, it didn’t seem like penny stocks would move the needle,” DiIorio said. But just in December 2011, UBS’s trades in 32 penny stocks represented over half of the firm’s total share volume, according to his calculations.
In a one-line response to a series of detailed questions from The Intercept, UBS media relations director Peter Stack wrote in an email: “UBS applies strict due diligence and anti-money-laundering standards to all its business.”
After some research, DiIorio became even more disturbed by the presence of the other company, Knight Capital, which has traded an average of more than 2 billion shares of penny stocks daily for the past three years.
Based in Jersey City, N.J., Knight is what is called a “market maker,” a dealer that facilitates trading by actually holding shares itself, if ever so briefly, so investors can buy and sell without any delay. “They’re selling the service of convenience to investors, like a car dealer makes it easier to buy or sell a car quickly,” said Jim Angel, an associate professor specializing in market structure at Georgetown University.
Knight Capital is a giant in the field; it alone was responsible for 11 percent of all trading in U.S. stocks by volume as of 2012. It’s known in particular for speed. The ability to jump in and out of stocks quickly through electronic markets is attractive to customers and enables Knight to trade nearly $30 billion every single day. “Market making is a business where the spreads are small but the volumes are large,” Angel said. The spread is the difference between the buy price and the sell price, and it’s how Knight makes money.
DiIorio looked closely at how Knight operated. He determined that between 80 and 90 percent of its share volumes came from penny and fractional penny stocks. According to DiIorio’s calculations, Knight traded over 10 trillion shares of OTC and Pink Sheets securities from 2004 to 2012.
This level of volume persists — the most recent statistics show that 73 percent of the company’s equity share volumes in August 2016 came from penny stocks, and 81 percent as recently as May.
A share in a penny stock is worth magnitudes less than a share in Google or Apple. But the spreads — where the market makers cash in — are proportionately bigger on a penny stock. For example, if the market maker earns a penny per share of a $50 stock, that’s only a spread of .02 percent. But a stock worth 25 cents where a market maker sees even a tenth of a penny in profit represents a spread of 2 percent — a 100-fold increase.
Still, DiIorio wondered how much volume a broker would need to make any money through penny stock trading. “You would have to move hundreds of millions of shares per trade,” he said.
And, because his personal investigation had started after his shares in a company called Best Rate Travel tanked precipitously, he also wondered: Why was Knight so involved with them in particular?
While DiIorio was mulling that, he started talking to his fellow traders and reading rumors online from owners of dozens of small companies who blamed the rapid destruction of their penny stocks on a practice known as naked short selling.
Let’s take that step by step. A short sale, generally speaking, is a bet that a stock price will drop over time. Typically, short sellers borrow shares of a stock from a broker and sell them on the open market, hoping to buy them back at a cheaper price in the future and make money on the exchange. This can become a self-fulfilling prophecy, if done right. Short selling can cause a market panic, and the prices drop in the frenzy.
But in naked short selling, you don’t even borrow the stock. You sell additional, phantom shares. This is even more likely to drive down the price than regular shorting, because suddenly the supply is larger but the demand is the same. “I can think of a number of stocks where the shares on the short exceeded the shares ever issued by the company,” said Alabama Securities Commission Director Joseph Borg. “You can’t do that unless it’s naked.”
Naked short selling is, not surprisingly, illegal in most circumstances.
But market makers like Knight have an exemption from naked short selling restrictions, on the grounds that they use the practice to maintain liquidity in markets. For example, if there’s high demand for a stock, the market maker can fill orders even if it doesn’t have the shares available.
As the Securities and Exchange Commission explains, “A market maker engaged in bona fide market making, particularly in a fast-moving market, may need to sell the security short without having arranged to borrow shares.” This often occurs in thinly traded stocks, like penny stocks.
DiIorio reasoned that naked short selling would explain where all the trades were coming from on Best Rate Travel; while he and his counterparts were locked into their investments for a year after the company’s merger, maybe someone was flooding the market with shares and battering the stock with ease.
At this point, DiIorio had no evidence that Knight did anything but facilitate trades. But he began to suspect that Knight somehow used naked short selling for its own devices. DiIorio’s attempts to get some explanations from Knight were brushed off — as were The Intercept’s during the reporting of this series.
Did Knight manipulate the stock price of Best Rate Travel, costing DiIorio and other investors millions? If so, why? Who benefited? Who needed this obscure, tiny penny stock to tank?”- David Dayen
90,000,000 shares at almost $3,000,000 of UNVC stock has traded over the last 35 days and I believe it relates to this UNVC press release: https:www.businesswire.com/news/home/20120806006013/en/UNIVEC-announces-Stock-Repurchase-UNIVEC announces Stock Repurchase Plan August 06, 2012 01:47 PM Eastern Daylight Time OWINGS MILLS, Md.--(BUSINESS WIRE)--Univec, Inc. (OTC: UNVC) a specialty pharmaceutical company, announced that its Board of Directors have approved a stock repurchase program. Under the program management is authorized to repurchase up to 100,000,000 shares of the company's stock. The program may be limited or terminated at anytime without prior notice. Repurchase is based on profit and cash flow of the company. Under the stock repurchase program stock may be repurchased by the company from time to time in open market transaction or in privately negotiated transactions as permitted under the applicable rules and regulations. About Univec Univec, Inc. A minority business enterprise (MBE) is a Specialty Pharmaceutical Company that manufactures and distributes high cost Specialty Pharmaceuticals and Transdermal products. The company is focused on diseases such as Sickle Cell Anemia, Cancer, HIV/Aids, Hepatitis C., Multiple Sclerosis, Hemophilia and Smoking Cessation and Drug addiction. PPSI (PHYSICIAN AND PHARMACEUTICAL SERVICES, INC.) a subsidiary of Univec promotes and pays for pharmaceutical products though its network of pharmacies. The company through it’s “StarterScript” allows in lieu of a physician sample, a voucher or a co-payment card to be provide to the patient for a trial supply of medication redeemed at any of the nearly 55,000 retail pharmacies utilizing the PPSI real-time processing system. Forward Looking Statements This document may contain forward-looking statements based on current expectations that could be affected by the risks and uncertainties involved in Univec’s business. These risks and uncertainties include, but are not limited to, the risks described from time to time in Univec’s reports to the General Public and reporting agencies. Subsequent written or oral statements attributable to Univec or persons acting on its behalf are expressly qualified in their entirety by the cautionary statements in this document and those in Univec’s reports filed. Contacts Univec, Inc. David Dalton, President 443-253-0194 univec@univecinc.com
Couldn’t one suggest that millions of UNVC shares are being purchased?
$$$ UNVC $$$
How did the name change on ihub from Univec Inc. to Univec Conglomerate? Are you suggesting this was some type of a glitch?
It is odd that almost every other website experienced the same glitch.
$$$ UNVC $$$
$$$ Univec Conglomerate $$$
Ihub has Univec listed as Univec Conglomerate, don’t they?
$$$ UNVC $$$
The announcement didn’t expire did it? If so please provide a link.
$$$ UNVC $$$
UNVC CEO Dr. David Dalton is rolling up multiple companies into Univec Conglomerate.
90,000,000 shares at almost $3,000,000 of UNVC stock has traded over the last 35 days and I believe it relates to this UNVC press release: https:www.businesswire.com/news/home/20120806006013/en/UNIVEC-announces-Stock-Repurchase-UNIVEC announces Stock Repurchase Plan August 06, 2012 01:47 PM Eastern Daylight Time OWINGS MILLS, Md.--(BUSINESS WIRE)--Univec, Inc. (OTC: UNVC) a specialty pharmaceutical company, announced that its Board of Directors have approved a stock repurchase program. Under the program management is authorized to repurchase up to 100,000,000 shares of the company's stock. The program may be limited or terminated at anytime without prior notice. Repurchase is based on profit and cash flow of the company. Under the stock repurchase program stock may be repurchased by the company from time to time in open market transaction or in privately negotiated transactions as permitted under the applicable rules and regulations. About Univec Univec, Inc. A minority business enterprise (MBE) is a Specialty Pharmaceutical Company that manufactures and distributes high cost Specialty Pharmaceuticals and Transdermal products. The company is focused on diseases such as Sickle Cell Anemia, Cancer, HIV/Aids, Hepatitis C., Multiple Sclerosis, Hemophilia and Smoking Cessation and Drug addiction. PPSI (PHYSICIAN AND PHARMACEUTICAL SERVICES, INC.) a subsidiary of Univec promotes and pays for pharmaceutical products though its network of pharmacies. The company through it’s “StarterScript” allows in lieu of a physician sample, a voucher or a co-payment card to be provide to the patient for a trial supply of medication redeemed at any of the nearly 55,000 retail pharmacies utilizing the PPSI real-time processing system. Forward Looking Statements This document may contain forward-looking statements based on current expectations that could be affected by the risks and uncertainties involved in Univec’s business. These risks and uncertainties include, but are not limited to, the risks described from time to time in Univec’s reports to the General Public and reporting agencies. Subsequent written or oral statements attributable to Univec or persons acting on its behalf are expressly qualified in their entirety by the cautionary statements in this document and those in Univec’s reports filed. Contacts Univec, Inc. David Dalton, President 443-253-0194 univec@univecinc.com